Cambridge MedTech Bicycle Therapeutics has raised $555m in equity financing via a private placement. The Nasdaq-listed firm is developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. The financing includes participation from new and existing investors, and strengthens its balance sheet with a pro forma cash … Continue reading Cambridge firm in $555m private placement equity financing